TITLE

A Report on the International Transglutaminase Autoantibody Workshop for Celiac Disease

AUTHOR(S)
Li, Marcella; Liping Yu; Tiberti, Claudio; Bonamico, Margherita; Taki, Iman; Dongmei Miao; Murray, Joseph A.; Rewers, Marian J.; Hoffenberg, Edward J.; Agardh, Daniel; Mueller, Patricia; Stern, Martin; Bonifacio, Ezio; Liu, Edwin
PUB. DATE
January 2009
SOURCE
American Journal of Gastroenterology;Jan2009, Vol. 104 Issue 1, p154
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVES: Measurement of transglutaminase autoantibodies (TGAA) is considered to be the most efficient single serologic test for celiac disease (CD) by the American Gastroenterological Association Institute. We hypothesized that a large international collaborative effort toward improving and standardizing TGAA measurement is both feasible and necessary. The primary aim of this workshop is to compare TGAA assays among various research and clinical laboratories and examine assay concordance and improve (and eventually standardize) the TGAA assay. METHODS: A total of 20 laboratories (5 commercial laboratories, 15 research and clinical laboratories) participated that included enzyme-linked immunosorbent assay (ELISA) and radiobinding assays. A total of 150 serum samples were distributed to each laboratory, with each laboratory receiving an equal aliquot that was coded and blinded, composed of 100 healthy control sera and 50 CD sera. RESULTS: Laboratory sensitivity ranged from 69% to 93% and specificity ranged from 96% to 100% . By receiver operator characteristic analysis, the area under the curve (C index) ranged from 0.9488 to 0.9904. When analyzing for linear correlation, r-squared was as high as 0.8882 but as low as 0.4244 for the celiac samples between different laboratories performing ELISA. CONCLUSIONS: This transglutaminase autoantibody workshop allows for larger-scale international participation for the purposes of improving and eventually standardizing the TGAA assay with subsequent workshops.
ACCESSION #
43984168

 

Related Articles

  • Autoantibodies of patients with coeliac disease are insufficient to block tissue transglutaminase activity. Dieterich W; Trapp D; Esslinger B; Leidenberger M; Piper J; Hahn E; Schuppan D // Gut;Nov2003, Vol. 52 Issue 11, p1562 

    BACKGROUND: and aims: Coeliac disease (CD) is characterised by the presence of autoantibodies against tissue transglutaminase (tTG), the endomysial autoantigen. This study was performed to determine the effect of purified autoantibodies on the enzymatic activity of tTG. METHODS: Total IgA and...

  • Detection of Autoantibodies Against Tissue Transglutaminase in Patients With Celiac Disease and Dermatitis Herpetiformis. Koop, Irmtraut; Ilchmann, Ralf; Izzi, Leo; Adragna, Amelia; Koop, Herbert; Barthelmes, Hans // American Journal of Gastroenterology;Aug2000, Vol. 95 Issue 8, p2009 

    OBJECTIVE: Endomysial autoantibodies (EmA) are specific for celiac disease. The target antigen has been identified as tissue tranglutaminase (tTG). Our aim was to study the accuracy of a newly developed enzyme-linked immunosorbent assay (ELISA) for easy detection of tTG autoantibodies. METHODS:...

  • Galactosylation of Serum IgA1 O-Glycans in Celiac Disease. Lindfors, Katri; Suzuki, Hitoshi; Novak, Jan; Collin, Pekka; Saavalainen, Päivi; Koskinen, Lotta; Mäki, Markku; Kaukinen, Katri // Journal of Clinical Immunology;Jan2011, Vol. 31 Issue 1, p74 

    In celiac disease, gluten ingestion provokes small-bowel mucosal injury and production of IgA autoantibodies against transglutaminase 2 (TG2). It has been suggested that in celiac patients IgA could mediate the transepithelial passage of gluten peptides in a mechanism involving the transferrin...

  • High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions. Di Niro, Roberto; Mesin, Luka; Zheng, Nai-Ying; Stamnaes, Jorunn; Morrissey, Michael; Lee, Jane-Hwei; Huang, Min; Iversen, Rasmus; du Pré, M Fleur; Qiao, Shuo-Wang; Lundin, Knut E A; Wilson, Patrick C; Sollid, Ludvig M // Nature Medicine;Mar2012, Vol. 18 Issue 3, p441 

    Celiac disease is an immune-mediated disorder in which mucosal autoantibodies to the enzyme transglutaminase 2 (TG2) are generated in response to the exogenous antigen gluten in individuals who express human leukocyte antigen HLA-DQ2 or HLA-DQ8 (ref. 3). We assessed in a comprehensive and...

  • Majority of Children With Type 1 Diabetes Produce and Deposit Anti-Tissue Transglutaminase Antibodies in the Small Intestine. Maglio, Mariantonia; Florian, Fiorella; Vecchiet, Monica; Auricchio, Renata; Paparo, Francesco; Spadaro, Raffaella; Zanzi, Delia; Rapacciuolo, Luciano; Franzese, Adriana; Sblattero, Daniele; Marzari, Roberto; Troncone, Riccardo // Diabetes;Jul2009, Vol. 58 Issue 7, p1578 

    OBJECTIVE--Anti-tissue transglutaminase (TG2) antibodies are the serological marker of celiac disease. Given the close association between celiac disease and type 1 diabetes, we investigated the production and deposition of anti-TG2 antibodies in the jejunal mucosa of type 1 diabetic children....

  • Missing endomysial and reticulin binding of coeliac antibodies in transglutaminase 2 knockout tissues. Korponay-Szabó, I.R.; Laurila, K.; Szondy, Z.; Halttunen, T.; Szalai, Z.; Dahlbom, I.; Rantala, I.; Kovács, J.B.; Fésüs, L.; Máki, M. // Gut;Feb2003, Vol. 52 Issue 2, p199 

    Background: Autoantibodies against transglutaminase 2 (TG2) are thought to be responsible for the endomysial (EMA), reticulin (ARA), and jejunal antibody (JEA) tissue binding of serum samples from coeliac patients but the exclusive role of TG2 in these staining patterns has not yet been...

  • The role of antitissue transglutaminase assay for the daignosis and monitoring of coeliac disease: a French—Italian muticentre study. Tonutti, E.; Visentini, D.; Bizzara, N.; Caradonna, M.; Cerni, L.; Villalta, D.; Tozzoli, R. // Journal of Clinical Pathology;May2003, Vol. 56 Issue 5, p389 

    Aims: Tissue transglutaminase (tTG) was recently identified as the major autoantigen in coeliac disease. The aim of this multicentre study was to evaluate the impact of a new immunoenzymatic assay for the detection of IgA anti-tGT antibodies. Methods: Seventy four Italian and French clinical...

  • Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ. Esposito, C.; Paparo, F.; Caputo, I.; Rossi, M.; Maglio, M.; Sblattero, D.; Not, T.; Porta, R.; Auricchio, S.; Marzari, R.; Troncone, R. // Gut;Aug2002, Vol. 51 Issue 2, p177 

    Background and aims: Coeliac disease (CD) is a multifactorial disorder which has an autoimmune component characterised by the occurrence of disease specific autoreactive antibodies against the enzyme tissue transglutaminase (tTG). The aim of this study was to investigate whether binding of...

  • Value of a screening algorithm for celiac disease using tissue transglutaminase antibodies as first level in a population-based study. Gomez, Juan C.; Selvaggio, Gisella; Pizarro, Bibiana; Viola, Martin J.; La Motta, Graciela; Smecuol, Edgardo; Castelletto, Roberto; Echeverrıa, Raúl; Vazquez, Horacio; Mazure, Roberto; Crivelli, Adriana; Sugai, Emilia; Mauriño, Eduardo; Bai, Julio C. // American Journal of Gastroenterology;Nov2002, Vol. 97 Issue 11, p2785 

    OBJECTIVE:Serological screening for celiac disease (CD) can detect a large number of otherwise undiagnosed patients based on the sequential evaluation of serological tests and intestinal biopsy. The aim of this study was to compare the screening value for CD of two different protocols for the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics